ASPS 2025 Statistics Report Highlights Continued Demand for Aesthetic Treatments, Volume Restoration and Healthy Aging

The American Society of Plastic Surgeons (ASPS) has released its 2025 Procedural Statistics Report, offering a snapshot of evolving patient preferences across aesthetic medicine. While the report documents growth in cosmetic surgery overall, several findings are particularly relevant for medical spas, where demand for non-surgical rejuvenation, skin treatments and age-management services continues to shape the market.

According to ASPS, cosmetic surgical procedures increased 7% in 2025 compared with the previous year, driven largely by patients seeking restoration after weight loss, aging and other life changes rather than dramatic transformation. ASPS President C. Bob Basu, MD, noted in a statement that today’s patients increasingly want to “look and feel more like themselves” and are pursuing treatments that restore volume, improve skin quality and address changes associated with aging.

Key Statistics from ASPS 2025

• Neuromodulators accounted for 50% of all minimally invasive procedures.
• Hyaluronic acid fillers represented 30% of minimally invasive procedures.
• Together, neuromodulators and HA fillers made up 80% of minimally invasive treatments.
• 82% of ASPS surgeons reported consultations related to GLP-1 use.
• Facial fat grafting increased 39%, reflecting strong demand for volume restoration.
• Laser skin treatments remained among the most-performed minimally invasive procedures.
• Adults age 66+ posted a 24% increase in cosmetic procedure volume, the fastest-growing patient segment.

For medical spas, perhaps the most significant takeaway is the continued dominance of minimally invasive treatments. Neuromodulator injections accounted for 50% of all minimally invasive procedures performed in 2025, while hyaluronic acid fillers represented another 30%, meaning the two categories together comprised 80% of all minimally invasive plastic surgery procedures reported by ASPS.

The report also underscores growing interest in volume restoration. Facial fat grafting posted the largest year-over-year increase among tracked procedures, rising 39%. While fat grafting itself is surgical, the trend reflects a broader patient preference for restoring youthful facial volume rather than simply tightening tissue, a philosophy that aligns closely with the continued popularity of dermal fillers and biostimulatory treatments in medical spa settings.

Another notable trend is the continued impact of GLP-1 weight loss medications on aesthetic practices. ASPS reports that 82% of member surgeons received consultation requests related to GLP-1 use in 2025. The report does not establish a direct connection between GLP-1 use and any specific procedure increases, but surgeons reported growing patient interest in addressing concerns such as skin laxity, volume loss and excess skin following significant weight loss.

For medical spas, these patients may represent an expanding opportunity for non-surgical treatment plans focused on skin quality, collagen stimulation, facial rejuvenation and body contouring. The data suggest that post-weight-loss aesthetic care remains a significant conversation across the industry.

The report also points to continued demand for energy-based and skin rejuvenation treatments. Among minimally invasive procedures, laser skin treatments remained one of the top categories nationwide, joining neuromodulators and fillers as leading aesthetic treatment options. ASPS also highlighted intense pulsed light (IPL), hair removal and tattoo removal among the most commonly performed minimally invasive procedures.

Demographically, older adults are driving some of the strongest growth in aesthetics. Patients age 66 and older recorded a 24% increase in cosmetic procedure volume, the largest gain of any age group. Meanwhile, procedure volume declined among patients younger than 36. ASPS noted that adults ages 36 to 55 still account for nearly half of all cosmetic procedures performed, but the data suggest growing demand from older patients seeking to maintain an active lifestyle and healthy appearance as they age.

Taken together, the ASPS data point to several themes likely to resonate with medical spa operators in 2026: ongoing demand for injectables, increasing interest in volume restoration, a growing post-GLP-1 patient population and expanding opportunities to serve healthy-aging consumers. While treatment preferences continue to evolve, patients remain focused on natural-looking outcomes, restoration and personalized aesthetic care.